Living With Sickle Cell Disease in the COVID-19 Pandemic
This study is completed. It focuses on anxiety and currently lists study information in the United States.
In Bethesda
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on anxiety and currently lists study information in the United States.
In BethesdaThis study is enrolling by invitation. It focuses on depression and currently lists participation information in the United States.
In Palo AltoThis study is enrolling by invitation. It focuses on depression and currently lists participation information in China.
In Hong KongThis study has public registry information in the United States. It focuses on schizophrenia.
In CatonsvilleThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In OmahaThis study is enrolling by invitation. It focuses on depression and currently lists participation information in the United States.
In New HavenThis study has public registry information. It focuses on depression and currently lists study information in the United States.
In LebanonThis study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including TucsonThis study is completed. It focuses on schizophrenia and currently lists study information in Nigeria.
Multiple locations, including MakurdiThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In New YorkThis study is completed. It focuses on ADHD and currently lists study information in the Netherlands.
In AmsterdamThis study is completed. It focuses on ADHD and currently lists study information in Sweden.
In Gothenburg